A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...
A new database targeting chronic urinary tract infections (UTIs)—a long-overlooked condition that may begin in childhood—is ...
HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced a Phase 2 clinical study protocol developed in ...
To sum up, GH001 has shown us pretty robust efficacy, a strong safety profile, and durable antidepressant effects. Going into ...
Independent analysis examines what published KSM-66 ashwagandha research shows at clinically studied dosages, where Testosil ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Fred D. Ledley, Bentley University (THE CONVERSATION) As a young medical student in ...
President Trump announced on Wednesday that he was withdrawing the United States from the bedrock international agreement ...
Something strange is happening with malnutrition. It’s by far the fastest-growing cause of death in America, soaring sixfold ...
Introduction Many neonatal deaths are avoidable using existing low-cost evidence-based interventions. This study evaluated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback